Semaglutide is well tolerated without any danger of hypoglycaemia in monotherapy but suffers from gastrointestinal adverse effects. A substantial population impacted with COVID-19 an infection were diabetic; hence use of semaglutide in diabetes together with CV individuals would be greatly supportive in keeping wellness care system throughout this pandemic condition. https://epicurusy221mbl5.kylieblog.com/profile